Wyndgate Announces Over $4 Million in Channel Partner Sales DENVER, Sept. 12 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med"), announced today the highest demand yet for its blood bank management software systems. Included in this growth is the marked success of the Company's channel partners, contributing over $4 million in sales to date for 2005 alone. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) In response to the success of its channel partners, Michael I. Ruxin, M.D., Chairman and CEO of Global Med Technologies, Inc. stated, "We greatly value the relationships we have with our channel partners and their customers. One of Wyndgate's major focuses has been to cultivate those relationships and we are pleased to see our channel partners experiencing such high demand for our product." Dr. Ruxin added, "We look forward to continuing the work with our channel partners to bring Wyndgate's blood banking solutions to new customers, and we anticipate that our strong double-digit growth will continue." Thomas F. Marcinek, Global Med's President and COO, said, "Wyndgate is in a period of rapid growth and our channel partners' sales have become a major contributor to that growth. Their escalating sales are an excellent complement to Wyndgate's direct sales and marketing achievements, and we are delighted to see our partners benefiting as well." Mr. Marcinek went on to say, "Through Service 360(TM), we are committed to continued delivery of quality products, services, and customer satisfaction that create increasing demand for our products, thus providing increased value for both our customers and channel partners." About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Sahara Africa. Together, the SafeTrace Tx advanced transfusion management system and the SafeTrace(R) donor management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D., of Global Med Technologies, +1-303-238-2000; or John Nesbett or Jordan Silverstein of The Investor Relations Group, +1-212-825-3210, for Global Med Technologies Web site: http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ Web site: http://www.globalmedtech.com/

Copyright